The therapeutic efficacy of TVQC correlated with significant induction of total and IFNg-producing tumor-antigen-specific CD8 T cells (Figure 3D) and NKDCs expressing granzyme B, IFNg or both (Figure 3E) in the tumor when compared to the untreated controls. The gene discussed is CD8A; the disease is neoplasm.